# Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer

> **NCT00348816** · PHASE2 · TERMINATED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 21 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** docetaxel
- **DRUG:** prednisone
- **PROCEDURE:** Radical prostatectomy
- **RADIATION:** Radiation therapy

## Key facts

- **NCT ID:** NCT00348816
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-05
- **Primary completion:** 2016-07-08
- **Final completion:** 2016-07-08
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Loss of funding
- **Last updated:** 2017-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00348816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00348816, "Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00348816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*